Shohei Matsufuji

Saga, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

ASO Visual Abstract: Short- and Long-Term Outcomes of Robotic Versus Conventional Minimally Invasive Esophagectomy for Esophageal Cancer: A Multicenter Propensity Score-Matched Cohort Study.

ASO Visual Abstract: Short- and Long-Term Outcomes of Robotic Versus Conventional Minimally Invasive Esophagectomy for Esophageal Cancer: A Multicenter Propensity Score-Matched Cohort Study.

Journal: Annals of surgical oncology

Published: February 25, 2026

Successful Endoscopic Removal and Closure of a Large Esophageal Perforation Following Accidental Ingestion of a Dental Prosthesis.

Successful Endoscopic Removal and Closure of a Large Esophageal Perforation Following Accidental Ingestion of a Dental Prosthesis.

Journal: DEN open

Published: November 03, 2025

BMP4 derived from human gastrointestinal carcinoma cells impairs myogenic differentiation: A possible in vitro mechanism of cancer‑induced cachexia.

BMP4 derived from human gastrointestinal carcinoma cells impairs myogenic differentiation: A possible in vitro mechanism of cancer‑induced cachexia.

Journal: International journal of oncology

Published: October 24, 2025

Putative Role of Fatty Acid Metabolic Therapy Using Ketogenic Diet and HIF-1α Inhibition in Hepatocellular Carcinoma: Evidence from an In Vitro Study.

Putative Role of Fatty Acid Metabolic Therapy Using Ketogenic Diet and HIF-1α Inhibition in Hepatocellular Carcinoma: Evidence from an In Vitro Study.

Journal: International journal of molecular sciences

Published: September 29, 2025

Short- and Long-term Outcomes of Robotic versus Conventional Minimally Invasive Esophagectomy for Esophageal Cancer: A Multicenter Propensity Score-matched Cohort Study.

Short- and Long-term Outcomes of Robotic versus Conventional Minimally Invasive Esophagectomy for Esophageal Cancer: A Multicenter Propensity Score-matched Cohort Study.

Journal: Annals of surgical oncology

Published: May 19, 2025

A HIF-1α inhibitor combined with palmitic acid and L-carnitine treatment can prevent the fat metabolic reprogramming under hypoxia and induce apoptosis in hepatocellular carcinoma cells.

A HIF-1α inhibitor combined with palmitic acid and L-carnitine treatment can prevent the fat metabolic reprogramming under hypoxia and induce apoptosis in hepatocellular carcinoma cells.

Journal: Cancer & metabolism

Published: August 23, 2023

Suppression of NASH-Related HCC by Farnesyltransferase Inhibitor through Inhibition of Inflammation and Hypoxia-Inducible Factor-1α Expression.

Suppression of NASH-Related HCC by Farnesyltransferase Inhibitor through Inhibition of Inflammation and Hypoxia-Inducible Factor-1α Expression.

Journal: International journal of molecular sciences

Published: June 05, 2023

Matrix metalloproteinase‑1 expression is regulated by HIF‑1‑dependent and epigenetic mechanisms and serves a tumor‑suppressive role in gastric cancer progression.

Matrix metalloproteinase‑1 expression is regulated by HIF‑1‑dependent and epigenetic mechanisms and serves a tumor‑suppressive role in gastric cancer progression.

Journal: International journal of oncology

Published: June 18, 2021

Antitumor effects of low-dose tipifarnib on the mTOR signaling pathway and reactive oxygen species production in HIF-1α-expressing gastric cancer cells.

Antitumor effects of low-dose tipifarnib on the mTOR signaling pathway and reactive oxygen species production in HIF-1α-expressing gastric cancer cells.

Journal: FEBS open bio

Published: November 10, 2020

Clinical Features, Prognosis, Diagnostic Approaches and Treatment of Multiple Primary Malignancies in the Digestive System.

Clinical Features, Prognosis, Diagnostic Approaches and Treatment of Multiple Primary Malignancies in the Digestive System.

Journal: Anticancer research

Published: October 18, 2019

Showing 1-10 of 10

Last Updated: 09/26/2026